Development of a cytotoxic T‐lymphocyte‐based, broadly protective influenza vaccine
Identifieur interne : 001432 ( Main/Exploration ); précédent : 001431; suivant : 001433Development of a cytotoxic T‐lymphocyte‐based, broadly protective influenza vaccine
Auteurs : Tetsuya Uchida [Japon]Source :
- Microbiology and Immunology [ 0385-5600 ] ; 2011-01.
Descripteurs français
- KwdFr :
- MESH :
- administration et posologie : Liposomes.
- immunologie : Lymphocytes T cytotoxiques, Vaccins antigrippaux.
- physiologie : Cellules présentatrices d'antigène.
- Animaux, Déterminants antigéniques des lymphocytes T, Grippe humaine, Humains, Mémoire immunologique.
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Liposomes.
- chemical , immunology : Influenza Vaccines.
- chemical : Epitopes, T-Lymphocyte.
- immunology : T-Lymphocytes, Cytotoxic.
- physiology : Antigen-Presenting Cells.
- prevention & control : Influenza, Human.
- Animals, Humans, Immunologic Memory.
Abstract
The current vaccination strategy against influenza is to induce production of antibodies directed against the surface antigens of these viruses. However, frequent changes in the surface antigens of influenza viruses allow them to avoid antibody‐mediated immunity. On the other hand, it is known that cytotoxic T‐lymphocyte (CTL) populations directed against internal antigens of influenza A virus are broadly cross‐reactive to influenza virus subtypes. The present authors have previously demonstrated that antigens chemically coupled to the surface of liposomes made using unsaturated fatty acids are cross‐presented by APCs via MHC class I to CD8+ T cells and induce antigen‐specific CTLs. Based on this finding, a liposome vaccine that is capable of inducing CTL response against internal antigens of influenza viruses and removing virus‐infected cells in the host has been developed. The CTL‐based liposomal technique might be applicable for developing vaccines against influenza and other viruses, such as hepatitis C, HIV, and severe acute respiratory syndrome corona virus, which frequently change their surface antigenic molecules.
Url:
DOI: 10.1111/j.1348-0421.2010.00273.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000325
- to stream Istex, to step Curation: 000292
- to stream Istex, to step Checkpoint: 000092
- to stream PubMed, to step Corpus: 000D27
- to stream PubMed, to step Curation: 000D27
- to stream PubMed, to step Checkpoint: 000D10
- to stream Ncbi, to step Merge: 000241
- to stream Ncbi, to step Curation: 000241
- to stream Ncbi, to step Checkpoint: 000241
- to stream Main, to step Merge: 001434
- to stream Main, to step Curation: 001432
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Development of a cytotoxic T‐lymphocyte‐based, broadly protective influenza vaccine</title><author><name sortKey="Uchida, Tetsuya" sort="Uchida, Tetsuya" uniqKey="Uchida T" first="Tetsuya" last="Uchida">Tetsuya Uchida</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6F31DFF4AF119D0C8EDCAFB9B74ABD9B216FF125</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1111/j.1348-0421.2010.00273.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-KG8VJBZH-Q/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000325</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000325</idno><idno type="wicri:Area/Istex/Curation">000292</idno><idno type="wicri:Area/Istex/Checkpoint">000092</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000092</idno><idno type="wicri:doubleKey">0385-5600:2011:Uchida T:development:of:a</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:21175770</idno><idno type="wicri:Area/PubMed/Corpus">000D27</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000D27</idno><idno type="wicri:Area/PubMed/Curation">000D27</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000D27</idno><idno type="wicri:Area/PubMed/Checkpoint">000D10</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000D10</idno><idno type="wicri:Area/Ncbi/Merge">000241</idno><idno type="wicri:Area/Ncbi/Curation">000241</idno><idno type="wicri:Area/Ncbi/Checkpoint">000241</idno><idno type="wicri:doubleKey">0385-5600:2011:Uchida T:development:of:a</idno><idno type="wicri:Area/Main/Merge">001434</idno><idno type="wicri:Area/Main/Curation">001432</idno><idno type="wicri:Area/Main/Exploration">001432</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Development of a cytotoxic T‐lymphocyte‐based, broadly protective influenza vaccine</title><author><name sortKey="Uchida, Tetsuya" sort="Uchida, Tetsuya" uniqKey="Uchida T" first="Tetsuya" last="Uchida">Tetsuya Uchida</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, 4‐7‐1 Gakuen, Musashimurayama‐City, Tokyo 208‐0011</wicri:regionArea><placeName><settlement type="city">Tokyo</settlement><region type="région">Région de Kantō</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Microbiology and Immunology</title><title level="j" type="alt">MICROBIOLOGY IMMUNOLOGY</title><idno type="ISSN">0385-5600</idno><idno type="eISSN">1348-0421</idno><imprint><biblScope unit="vol">55</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="19">19</biblScope><biblScope unit="page" to="27">27</biblScope><biblScope unit="page-count">9</biblScope><publisher>Blackwell Publishing Asia</publisher><pubPlace>Melbourne, Australia</pubPlace><date type="published" when="2011-01">2011-01</date></imprint><idno type="ISSN">0385-5600</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0385-5600</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antigen-Presenting Cells (physiology)</term><term>Epitopes, T-Lymphocyte</term><term>Humans</term><term>Immunologic Memory</term><term>Influenza Vaccines (immunology)</term><term>Influenza, Human (prevention & control)</term><term>Liposomes (administration & dosage)</term><term>T-Lymphocytes, Cytotoxic (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Cellules présentatrices d'antigène (physiologie)</term><term>Déterminants antigéniques des lymphocytes T</term><term>Grippe humaine ()</term><term>Humains</term><term>Liposomes (administration et posologie)</term><term>Lymphocytes T cytotoxiques (immunologie)</term><term>Mémoire immunologique</term><term>Vaccins antigrippaux (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Liposomes</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Epitopes, T-Lymphocyte</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Liposomes</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Lymphocytes T cytotoxiques</term><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>T-Lymphocytes, Cytotoxic</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Cellules présentatrices d'antigène</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Antigen-Presenting Cells</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Humans</term><term>Immunologic Memory</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Déterminants antigéniques des lymphocytes T</term><term>Grippe humaine</term><term>Humains</term><term>Mémoire immunologique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The current vaccination strategy against influenza is to induce production of antibodies directed against the surface antigens of these viruses. However, frequent changes in the surface antigens of influenza viruses allow them to avoid antibody‐mediated immunity. On the other hand, it is known that cytotoxic T‐lymphocyte (CTL) populations directed against internal antigens of influenza A virus are broadly cross‐reactive to influenza virus subtypes. The present authors have previously demonstrated that antigens chemically coupled to the surface of liposomes made using unsaturated fatty acids are cross‐presented by APCs via MHC class I to CD8+ T cells and induce antigen‐specific CTLs. Based on this finding, a liposome vaccine that is capable of inducing CTL response against internal antigens of influenza viruses and removing virus‐infected cells in the host has been developed. The CTL‐based liposomal technique might be applicable for developing vaccines against influenza and other viruses, such as hepatitis C, HIV, and severe acute respiratory syndrome corona virus, which frequently change their surface antigenic molecules.</div></front></TEI><affiliations><list><country><li>Japon</li></country><region><li>Région de Kantō</li></region><settlement><li>Tokyo</li></settlement></list><tree><country name="Japon"><region name="Région de Kantō"><name sortKey="Uchida, Tetsuya" sort="Uchida, Tetsuya" uniqKey="Uchida T" first="Tetsuya" last="Uchida">Tetsuya Uchida</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001432 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001432 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:6F31DFF4AF119D0C8EDCAFB9B74ABD9B216FF125
|texte= Development of a cytotoxic T‐lymphocyte‐based, broadly protective influenza vaccine
}}
| This area was generated with Dilib version V0.6.33. |  |